GlassScriptPhysician profile
Raveendra S Morchi
NPI 1912016262
$2,617.27
in general payments reported to CMS, 2019-2025
10 companies · $933 in 2025
The $933 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.52 · 2021: $568 · 2022: $225 · 2023: $228 · 2024: $606 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,768.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,767.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,112.81 | 2022-2025 | Impella |
| Edwards Lifesciences Corporation | $663.83 | 2020-2025 | Sapien 3 Ultra Resilia |
| Atricure, INC. | $238.25 | 2020-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Ethicon US, LLC | $193.20 | 2025 | Prolene, Ethicon, Stratafix |
| Medical Device Business Services, INC. | $107.69 | 2021 | |
| Abbott Laboratories | $99.88 | 2023 | Amplatzer Piccolo |
| Baxter Healthcare | $60.56 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $58.26 | 2024-2025 | Assure Wcd |
| Medtronic, INC. | $42.75 | 2023 | Penditure |
| Depuy Synthes Sales INC. | $40.04 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raveendra Morchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.